Patent Grant
9615766
The present invention relates to a method and apparatus for performing impedance measurements, and in particular to performing multiple impedance measurements at a given site to determine an indicator indicative of the presence, absence or degree of anomalies such as tissue lesions.
The reference in this specification to any prior publication (or information derived from it), or to any matter which is known, is not, and should not be taken as an acknowledgment or admission or any form of suggestion that the prior publication (or information derived from it) or known matter forms part of the common general knowledge in the field of endeavour to which this specification relates.
Presently, the detection of the existence of certain biological lesions or anomalies within a region requires the use of methods which are not only invasive but also require a sample of the region to be removed and sent away for biological testing.
For example, in the detection of cervical cancer, it is often the case that a patient will undergo several tests typically beginning with a Pap Smear (the Papanicolaou test) which includes a tool that is used to gather cells from the cervical region. If the Pap Smear result is positive, a patient may then undergo biopsies which will require the removal of a sample area of the suspected region.
It will be appreciated that these methods can cause severe discomfort for persons undergoing the tests, and furthermore, the tests may not always provide a high degree of accuracy.
One existing technique for determining biological parameters relating to a subject, such as fluid levels, involves the use of bioelectrical impedance. This involves measuring the electrical impedance of a subject's body using a series of electrodes placed on the skin surface. Changes in electrical impedance at the body's surface are used to determine parameters, such as changes in fluid levels, associated with the cardiac cycle or oedema, or other conditions which affect body habitus.
GB2426824 describes a probe for measuring the electrical impedance of human or animal body tissue comprises a housing and at least two electrodes mounted on the surface of the housing. Contained within the housing are: a current source coupled to the electrodes, a controller to control the current source to drive a current between the electrodes, a voltmeter to measure potential difference between the electrodes, and a communication circuit for wirelessly transmitting the measured potential difference to a remote device. The probe may also include a processor to calculate tissue impedance from the measured potential difference, in which case the communication circuit transmits the calculated impedance. Wireless telemetry may be via an optical or radio frequency (RF) connection, for example using an infra red transmitter. The transmission of data without the use of a wired connection improves measurement accuracy due to the removal of the parasitic capacitances arising from cable connections. The probe may be used for cancer screening. A method of measuring impedance is also disclosed.
The present invention seeks to substantially overcome, or at least ameliorate, one or more disadvantages of existing arrangements.
In a first broad form, the present invention seeks to provide apparatus for use in performing impedance measurements on a subject, the apparatus including:
Typically at least part of the probe is configured to be inserted into the subject so that at least some of the electrodes are in contact with cervical tissues.
Typically the probe includes:
Typically the probe portion is removably attached to the handle portion.
Typically the probe portion is for insertion into the subject.
Typically the handle portion includes at least one of:
Typically the processing system includes a first processing system and a second processing system and wherein at least one of the first and second processing systems is provided in the handle portion.
Typically the apparatus includes:
Typically the apparatus includes a switching device for selectively interconnecting the signal generator and sensor to the electrodes.
Typically the apparatus includes a tetrapolar electrode arrangement, the first and second electrode configurations using a different configuration of drive and measurement electrodes.
Typically the apparatus includes an electrode array having a number of electrodes provided thereon, and wherein in use, selected ones of the electrodes are used as drive and measurement electrodes.
Typically the processing system:
Typically the processing system:
Typically the processing system:
Typically the apparatus includes a capacitance cancelling circuit for cancelling capacitance coupling between first and second electrodes.
Typically the capacitance cancelling circuit includes an inverting amplifier for coupling a signal generator output to a sensor input.
Typically the inverting amplifier applies a capacitance cancelling signal to the sensor input to thereby cancel any effective capacitance between the first electrode and the second electrode.
Typically an inverting amplifier output is coupled to the sensor input via at least one of:
Typically at least one of a resistor and capacitor are adjustable, thereby allowing a capacitance cancelling signal applied to the sensor input to be controlled.
Typically the apparatus includes an input capacitance cancelling circuit for cancelling an effective input capacitance at a sensor input.
Typically the apparatus includes a feedback loop for connecting a sensor output to the sensor input.
Typically the feedback loop includes at least one of:
Typically at least one of a resistor and capacitor are adjustable, thereby allowing a current flow from the sensor output to the sensor input to be controlled.
Typically the feedback loop applies an input capacitance cancelling signal to the sensor input to thereby cancel any effective capacitance at the sensor input.
Typically the processing system determines an impedance value for each of at least four electrode configurations.
Typically the apparatus includes a signal generator, a sensor, a switching device, and wherein the processing system controls the electrode configuration by:
Typically the processing system:
Typically the processing system:
Typically the processing system:
Typically the processing system, for a site having an anomaly, at least one of:
Typically the processing system:
Typically the processing system:
Typically the processing system, wherein the reference is a previously measured difference for the subject.
Typically the apparatus includes a store for storing the reference.
Typically the processing system:
Typically the impedance values are at least one of:
Typically the impedance parameter values include at least one of:
Typically the processing system determines the impedance parameter values at least in part using the equation:
Typically the processing system:
Typically the apparatus includes a measuring device for performing impedance measurements, the measuring device including the processing system.
Typically the anomaly includes any one or a combination of:
Typically the tissue anomaly is a tissue lesion.
Typically the apparatus is used to detect the presence, absence, or degree of cervical cancer.
Typically the processing system is for:
In a second broad form, the present invention seeks to provide a method for use in performing impedance measurements on a subject using a probe having a plurality of electrodes, the method including, in a processing system:
In a third broad form, the present invention seeks to provide apparatus for use in performing impedance measurements on a subject, the apparatus including a probe having:
In a fourth broad form, the present invention seeks to provide apparatus for use in performing impedance measurements on a subject, the apparatus including:
Typically the processing system selectively interconnects the signal generator and the sensor to electrodes in the array using the switching device, thereby allowing:
In a fifth broad form, the present invention seeks to provide a method for use in performing impedance measurements on a subject, the method including, in a processing system:
Typically the method includes using a tetrapolar electrode arrangement, the first and second electrode configurations using a different configuration of drive and measurement electrodes.
Typically the method includes, in the processing system, determining an impedance value for each of four electrode configurations.
Typically the method uses apparatus including a signal generator, a sensor, a switching device and an electrode array having a number of electrodes, and wherein the method includes in the processing system, controlling the electrode configuration by:
Typically the method includes, in the processing system:
Typically the method includes, in the processing system:
Typically the method includes, in the processing system:
Typically the method includes, in the processing system, for a site having an anomaly, at least one of:
Typically the method includes, in the processing system:
Typically the method includes, in the processing system:
Typically the reference is a previously measured difference for the subject.
Typically the method includes, in the processing system:
Typically the impedance values are at least one of:
Typically the impedance parameter values include at least one of:
Typically the method includes, in the processing system, determining the impedance parameter values at least in part using the equation:
Typically the method includes, in the processing system:
Typically the processing system forms part of a measuring device for performing impedance measurements.
Typically the anomaly includes any one or a combination of:
Typically the tissue anomaly is a tissue lesion.
Typically the impedance measurements are performed using apparatus including an electrode array having a number of electrodes provided thereon, and wherein the method includes, in the processing system, causing impedance measurements to be performed using different ones of the electrodes in the array.
Typically the method includes:
Typically the method includes:
Typically the method includes:
Typically the apparatus includes a signal generator for generating drive signals, a sensor for sensing measured signals, and a multiplexer, and wherein the method includes, in the processing system selectively interconnecting the signal generator and the sensor to electrodes in the array using the multiplexer.
In a sixth broad form, the present invention seeks to provide apparatus for use in performing impedance measurements on a subject, the apparatus including a processing system that:
It will be appreciated that the broad forms of the invention may be used individually or in combination, and may be used for diagnosis of the presence, absence or degree of a range of conditions and illnesses, including, but not limited to the detection of lesions, tumours, or the like, as well as to allow impedance mapping to be performed more accurately by accounting for erroneous readings.
The detection of lesions can be used both in cancer screening, as well as in the triage of abnormal cytology or a HPV high risk genotype positive result.
An example of the present invention will now be described with reference to the accompanying drawings, in which:
An example of apparatus suitable for performing an analysis of a subject's bioelectric impedance will now be described with reference to
As shown the apparatus includes a measuring device 100 including a processing system 102 coupled to a signal generator 111 and a sensor 112. In use the signal generator 111 and the sensor 112 are coupled to first electrodes 113, 114, and second electrodes 115, 116, provided on a subject S, via respective first leads 123, 124, and second leads 125, 126.
The connection may be via a switching device 118, such as a multiplexer, allowing the leads 123, 124, 125, 126 to be selectively interconnected to signal generator 111 and the sensor 112, although this is not essential, and connections may be made directly between the signal generator 111, the sensor 112 and the electrodes 113, 114, 115, 116.
Although only a single signal generator 111 and a single sensor 112 are shown in this example, this is not essential, and instead two signal generators 111 and two sensors 112 may be used, with each signal generator and each sensor being coupled to a respective one of the electrodes 113, 114, 115, 116 in use.
The processing system 102 typically includes a processor 105, a memory 106, an input/output device 107 such as a keyboard and display, and an external interface 108 coupled together via a bus 109, as shown. The external interface 108 can be used to allow the processing system 102 to be coupled to the signal generator 111 and the sensor 112, as well as to allow connection to one or more peripheral devices (not shown), such as an external database, or the like.
In use, the processing system 102 is adapted to generate control signals, which cause the signal generator 111 to generate one or more alternating drive signals, such as voltage or current signals, which can be applied to a subject S, via two of the electrodes 113, 114, 115, 116 (generally referred to as “drive” electrodes). The sensor 112 then determines measured signals representing the induced voltage across or current through the subject S, using the other two of the electrodes 113, 114, 115, 116 (generally referred to as “measurement” electrodes) and transfers appropriate signals to the processing system 102.
Accordingly, it will be appreciated that the processing system 102 may be any form of processing system which is suitable for generating appropriate control signals and interpreting an indication of the measured signals to thereby determine the subject's bioelectrical impedance, and optionally determine other information such as the presence, absence or degree of oedema, or the like.
The processing system 102 may therefore be a suitably programmed computer system, such as a laptop, desktop, PDA, smart phone or the like. Alternatively the processing system 102 may be formed from specialised hardware, such as an FPGA (field programmable gate array), or a combination of a programmed computer system and specialised hardware, or the like.
In one example, the processing system can be formed from first and second processing systems, such as a computer system and a processing system, such as an FPGA or the like. In this example, the computer system can be used to control the processing system, allowing the processing system to perform the measurement procedure, and allowing the computer system to be used to analyse the impedance measurements and displayed determined results. In a further example, the processing system can be incorporated into a measuring device, such as a probe, with the computer system being provided remotely to the measuring device.
The use of a separate computer system and processing system can lead to a number of benefits. For example, the processing system can be used to allow the custom hardware configuration to be adapted through the use of appropriate embedded software. This in turn allows a single measuring device to be used to perform a range of different types of analysis.
Secondly, this vastly reduces the processing requirements on the computer system. This in turn allows the computer system to be implemented using relatively straightforward hardware, whilst still allowing the measuring device to perform sufficient analysis to provide interpretation of the impedance. This can include for example displaying information such as relative fluid levels, body composition parameters, a “Wessel” plot, or other indicators, as well as using the impedance values to determine indicators, such as indicators indicative of the presence, absence or degree of anomalies such as lesions, or the like.
Thirdly, this allows the measuring device to be updated. Thus for example, if an improved measurement protocol is created, or an improved current sequence determined for a specific impedance measurement type, the measuring device can be updated by downloading new embedded software.
It will be appreciated however that this is not essential, and additionally, or alternatively, a single processing system may be used.
In use, the two electrodes 113, 114, 115, 116 that are to be used as drive electrodes are positioned on the subject to allow one or more signals to be injected into the subject S, with two other electrodes 113, 114, 115, 116 being positioned to act as measurement electrodes to allow signals induced within the subject, to be detected. The location of the electrodes will depend on the segment of the subject S under study, an example of which is shown in
Once the electrodes are positioned, one or more alternating signals are applied to the subject S, via the drive electrodes. The nature of the alternating signal will vary depending on the nature of the measuring device and the subsequent analysis being performed.
For example, the system can use Bioimpedance Analysis (BIA) in which a single low frequency current is injected into the subject S, with the measured impedance being used directly in the identification of anomalies (which can include tissue anomalies, erroneous measurements, or the like), or performing impedance mapping.
In contrast Bioimpedance Spectroscopy (BIS) devices apply signals at a number of frequencies either simultaneously or sequentially. BIS devices typically utilise frequencies ranging from low frequencies (4 kHz) to higher frequencies (1000 kHz), and can use 256 or more different frequencies within this range, to allow multiple impedance measurements to be made within this range.
Thus, the measuring device 100 may either apply an alternating signal at a single frequency, at a plurality of frequencies simultaneously, or may apply a number of alternating signals at different frequencies sequentially, depending on the preferred implementation. The frequency or frequency range of the applied signals may also depend on the analysis being performed.
In one example, the applied signal is a frequency rich current signal from a current source clamped, or otherwise limited, so it does not exceed a maximum allowable subject auxiliary current. However, alternatively, voltage signals may be applied, with a current induced in the subject being measured. The signal can either be constant current, impulse function or a constant voltage signal where the current is measured so it does not exceed the maximum allowable subject auxiliary current.
A potential difference and/or current are measured between the measurement electrodes. The acquired signal and the measured signal will be a superposition of potentials generated by the human body, such as the ECG, and potentials generated by the applied current.
To assist accurate measurement of the impedance, buffer circuits may be placed in connectors that are used to connect the electrodes 113, 114, 115, 116 to the leads 123, 124, 125, 126. This helps eliminate contributions to the measured voltage due to the response of the leads 123, 124, 125, 126, and reduce signal losses.
A further option is for the voltage to be measured differentially, meaning that the sensor used to measure the potential at each measurement electrode only needs to measure half of the potential as compared to a single ended system. In one example, current can also be driven or sourced through the subject S differentially, which again greatly reduced the parasitic capacitances by halving the common-mode current.
The acquired signal is demodulated to obtain the impedance of the system at the applied frequencies. One suitable method for demodulation of superposed frequencies is to use a Fast Fourier Transform (FFT) algorithm to transform the time domain data to the frequency domain. This is typically used when the applied current signal is a superposition of applied frequencies. Another technique not requiring windowing of the measured signal is a sliding window FFT.
In the event that the applied current signals are formed from a sweep of different frequencies, then it is more typical to use a processing technique such as multiplying the measured signal with a reference sine wave and cosine wave derived from the signal generator, or with measured sine and cosine waves, and integrating over a whole number of cycles. This process rejects any harmonic responses and significantly reduces random noise.
Other suitable digital and analogue demodulation techniques will be known to persons skilled in the field.
In the case of BIS, impedance or admittance measurements can be determined from the signals at each frequency by comparing the recorded voltage and current signal. This allows demodulation to be used to produce an amplitude and phase signal at each frequency.
In one example, the probe 130 has a handle portion 132, which includes the processing system 102, signal generator 111, sensor 112, and switching device 118. An optional remote computer system 131 may be provided. The probe 130 has a probe portion 134 attached to the handle portion 132, where the probe portion 134 can include the leads and electrodes such as, for example, the leads 123 to 126 and a number of electrodes 150 that are selectively connectable to the signal generator 111 and the sensor 112, via the switching device 118, thereby allowing the electrodes 150 to selectively acts as the drive and sense electrodes 113, 114, 115, 116. It can be seen that in this example, nine electrodes are shown provided in a 3×3 array, but this is for the purpose of example only, and in practice any number of electrodes may be provided, as will be described in more detail below.
In use, the handle portion 132 of the probe 130 can be used to handle the probe 130, allowing the probe portion 134 to be inserted into or near the cervix, so that the electrodes 150 are positioned in contact with tissue of interest. The operator then activates a measurement procedure, causing the apparatus to perform impedance measurements on the tissue, with the results being analysed to allow any biological anomalies or lesions of the cervix, such as cervical cancer, to be detected.
Accordingly, the probe portion is typically made of a biologically inert material, such as a polymer based material such as polystyrene, polyethylene, polypropylene, acrylates, methacrylates, acrylics, polyacrylamides, and vinyl polymers such as vinyl chloride and polyvinyl fluoride, ie plastics, or the like. The probe is also typically shaped to conform to the shape of the vagina and cervix, to allow for easy and comfortable insertion into the subject.
It will be appreciated that either the probe portion 134, or the entire probe 130 can be disposable, such that the probe portion 134 is used once for a patient in order to minimise the risk of disease transfer between patients. Additionally, either the probe portion 134 or the entire probe 130 can be formed such that they are able to be sterilised. Thus, in one particular example, the probe portion 134 can be removably attached to the handle portion 132, so that after use, the probe portion 134 can be removed and disposed of. Alternatively, the probe portion 134 can include a cover or sterilised sheath which can be changed for each patient.
Typically, the probe portion 134 is separable from the handle portion 132, allowing the probe portion 134 to be replaced for each subject being tested, however this is not essential and a single bodied probe could be used. However, by providing separate probe and handle portions 134, 132, this allows the probe portion 134 to contain only the electrodes and leads, and not any of the associated electronics. This allows the probe portion 134 to be constructed cheaply and easily, allowing this to be formed from a disposable unit. In contrast, the handle portion 132, includes processing electronics required to generate and analyse the electrical signals, and hence this part of the device will be more expensive, and is therefore typically designed for reuse. In a further example, the probe portion 134 can include basic electronics, such as capacitive cancelling circuits, although these may also be incorporated into the handle portion 132.
Alternative designs of probe portion 134 are shown in
In the event that multiple electrodes are provided in an array, the number of electrodes can be limited by the diameter of the probe portion 134. Accordingly, in an alternative example, the probe portion can include a head 136, which includes the electrodes 150 mounted thereon. The head 136 is in the form of a plate having the electrodes 150 mounted on one side thereof. In use, this allows the head to be inserted into the cervix and gently pressed against the side walls of the cervix, thereby allowing each of the electrodes 150 in the array to contact the cervical tissue. This in turn increases the number of electrodes 150 that can be brought into contact with the cervical tissue at any one time, allowing measurements to be performed at multiple sites, and in multiple configurations, without requiring adjustment of the probe position, and whilst maintaining a minimum physical volume for the probe portion 134. This in turn reduces discomfort for the subject.
An example of the operation of the apparatus to detect anomalies when performing impedance mapping or other impedance measurements will now be described with reference to
At step 200 a first impedance value is measured at a given site (such as for example, within the cervix). The impedance value is typically measured using a first electrode configuration, and whilst any form of electrode configuration may be used, this is typically a tetrapolar electrode configuration utilised to allow impedance readings to be measured at the specific site.
At step 210 a second impedance value is measured at the (same) site. This is typically achieved utilising an alternative electrode configuration and in particular, a configuration which is a modified version of the first configuration.
In this regard, the configuration typically utilises the same electrode placements on the subject, but applies the signals to and measures signals from different ones of the electrodes. Thus, for example, in a tetrapolar electrode configuration, the first measurement may be made by applying a current across first electrodes and measuring a voltage across second electrodes, whereas the second measurement may be made by applying the current across the second electrodes and measuring the induced voltage across first electrodes.
Typically, the preferred measurement option for a given site involves using first electrodes as the drive electrodes and second electrodes as the sense electrodes, for a first measurement. A second measurement is performed with one of the first and second electrodes acting as the drive electrodes, and with the other ones of the first and second electrodes acting as the sense electrodes, as will be described in more detail below.
At step 220 an indicator indicative of the presence, absence or degree of an anomaly using the first and second impedance values is determined. Thus, the indicator indicates if the measurement made at the site is erroneous or otherwise indicative of an anomaly. In particular, such a reading will typically arise if a low impedance lesion or other biological anomaly is present between a drive and a measurement electrode pair.
The indicator or anomaly can then be taken into account when performing analysis of impedance measurements at step 230. For example, the indicator may be used to identify and/or subsequently monitor the development of a low impedance lesion. Thus, this technique can be used to detect the presence, absence or degree of lesions or other biological anomalies. This can be used, for example, to identify cervical cancer, or the like. Additionally, and/or alternatively, knowledge of the anomaly can be taken into account when performing analysis of impedance measurements.
In one example, impedance measurements can be performed over a region, such as an area of a subject's skin, to allow impedance mapping or other similar analysis to be performed. As the presence of anomalies or other erroneous readings can have a negative impact on any such impedance mapping process, identification of these anomalies or erroneous readings allows readings at the corresponding site to be rejected or otherwise modified so that they do not adversely affect the impedance mapping process.
An example of the process for identifying anomalies, including but not limited to tissue anomalies, erroneous readings, or the like will now be described in more detail with respect to
In particular, at step 300 the signal generator 111 is used to apply a first drive signal to the subject S using a first electrode configuration. Thus for example, the current source 111 may be connected to the leads 123, 124, via the switching device 118, so that the electrodes 113, 114 act as the drive electrodes.
At step 310 a first signal induced across the subject S is measured. This is typically achieved by utilising the switching device 118 to interconnect the remaining measurement electrodes, in this case the electrodes 115, 116, to the sensor 112, thereby allowing signals induced within the subject S to be detected.
At step 320 the processing system 102 utilises an indication of the applied and induced signals to determine a first impedance value. The first impedance value may be formed from one or more measured impedance values. Thus, for example, if a single frequency BIA device is used, a single measured impedance value may be determined, whereas if a BIS device is used, multiple measured values may be determined, with a single value being determined for each applied frequency.
In addition, or alternatively to the impedance values being actual measured values, the impedance values may be based on impedance parameter values derived from the actual measurements. This can include parameter values such as the impedance at zero, characteristic or infinite frequencies (R0, Zc, R∞), as will be described in more detail below.
At step 330 the processing system 102 controls the switching device 118 to switch to an alternative electrode configuration. In this instance, for example, the electrodes 113, 115 may be used as the drive electrodes with the electrodes 114, 116 being used as measurement or sense electrodes. Any other alternative configuration may also be used, depending on the implementation.
At step 340, a second signal is applied to the subject S using the second electrode configuration, with the induced signal across subject S being measured at step 350. At step 360 the applied and induced signals are processed to determine a second impedance value, which again can be formed from one or more measured impedance values, or parameter values derived therefrom.
At step 370, the processing system 102 uses the first and second impedance values to determine if any tissue anomalies might exist. An erroneous measurement will typically be determined if the difference between the first and second impedance values is greater than a reference amount. The magnitude of this reference may vary depending upon a number of factors and the processing system 102 is therefore typically arranged to compare the difference between the first and second impedance values to a reference value, which can be stored in memory, or the like. The reference value could be previously determined for example based on sample data colleted for a nominal reference population, or based on the difference determined for other sites, as will be described in more detail below.
Once detected, this information can be used in one of two ways. For example, the measured values can be used to derive an indicator indicative of a biological anomaly, such as the presence, absence or degree of any tissue lesion, tumour, or the like, at step 380. The indicator can be in any one of a number of forms.
In one example, the indicator can be in the form of a numerical value or graphical representation thereof. The numerical value can be calculated, for example by comparing the difference between the first and second impedance values to a reference obtained from a normal population, or the like. Alternatively, the difference can be scaled relative to the reference. As a further alternative, the difference can be compared to a previously determined difference for the subject, allowing a longitudinal analysis to be performed. This allows variations in the difference over time to be monitored, which can in turn be indicative of the growth or reduction of the lesion. The indicator may also include thresholds, indicative of the presence, absence of lesions or other anomalies.
Alternatively, at step 390, the erroneous measurement can be taken into account when performing other impedance analysis. Thus, for example, if wound or other impedance mapping is being performed to monitor wound healing, or to perform large scale mapping of tissues, such as cervical tissue, or the like, any erroneous reading can be rejected to ensure that this does not overtly influence the outcome of the analysis. Examples of this will be described in more detail below.
An example of a specific apparatus arrangement for performing impedance measurements, and in particular, for performing impedance mapping, will now be described with reference to
In particular in this instance an impedance measuring device 400 is connected to a switching device in the form of a multiplexer 410, which is controlled by a processing system or computer system 420, such as a personal computer or the like. In this instance the multiplexer 410 is coupled to an electrode array 430 having a number of electrodes 431 provided thereon.
In use the measuring device 400 generates signals to be applied to the subject via the electrode array with these signals being coupled to respective ones of the electrodes 431 utilising the multiplexer 410. Similarly, signals induced across the subject S can also be returned from electrodes 431 to the impedance measuring device 400 via the multiplexer 410. Overall operation of the multiplexer 410 can be controlled using the computer system 420, allowing this process to be substantially automated.
In one specific example, the measuring device 400 is in the form of an Impedimed Imp SFB7™. The drive and measurement electrodes from the SFB7 can be directed through a multiplexer 410, such as a 32 channel multiplexer (ADG732) from Analog Devices and switching of the multiplexer output channels can be controlled via custom software operating on a standard computer system 420.
In this example, the electrode array 430 includes twenty five, 1 mm diameter electrodes separated by 0.77 mm in a 5×5 square. This allows a total of 64 separate measurements to be taken at 16 different sites giving an impedance map of 49 mm2 on the surface of a subject, which may be an individual, a test medium, or the like. As a result of this, only 25 of the available 32 multiplexer channels are required for this arrangement.
An example of use of the system will now be described with reference to
At step 500 the electrode array 430 is applied to the subject S, and connected to the multiplexer 410, as described above. At this stage, systems, such as the measuring device 400, the multiplexer 410 and the computer system 420 are activated and configured as required in order to allow the measurement procedure to be performed.
At step 510 the computer system 420 selects a next site for measurement. The electrodes 431 are typically selected so as to form a tetrapolar arrangement, with a group of four electrodes 431 in the array 430 defining the site being measured. An example of this is shown in
In this example, four measurements can be made at each site by using the drive and measurement electrode arrangements shown in
To achieve this, at step 520 the measuring device 400 controls the multiplexer 410 to couple the measuring device to the electrodes in accordance with a next one of the electrode configurations for the currently selected tetrapolar array. Thus, for example, for the first measurement, the arrangement shown in
The measuring device 400 then applies a drive signal to the subject via the selected drive electrodes 431C, 431D, allowing the signal induced across the measurement electrodes 431A, 431B to be measured at step 530. An indication of this measured signal is returned to the measuring device 400, to allow the measuring device 400 to process the voltage and current signals and determine one or more an impedance values.
The impedance values determined will depend on the preferred implementation. For example, in the event that the measuring device 400 is performing BIA, then typically a single impedance value is calculated representing the measured impedance.
In contrast, if the measuring device performs a multiple frequency BIS analysis, as is the case with the SFB7™ device described above, then the impedance value can be based on impedance parameter values, such as values of the impedance at zero, characteristic or infinite frequencies (R0, Zc, R∞), or an indicator indicative of the dispersion width of the impedance measurements (α). These values can be derived by the measuring device 400 based on the impedance response of the subject, which at a first level can be modelled using equation (1), commonly referred to as the Cole model:
However, the above represents an idealised situation which does not take into account the fact that the cell membrane is an imperfect capacitor. Taking this into account leads to a modified model in which:
The value of the impedance parameters R0 and R∞ may be determined in any one of a number of manners such as by:
It will be appreciated that as an alternative to the analysis being performed by the measuring device 400, the analysis can be performed in part, or in total, by the computer system 420, depending on the preferred implementation.
At step 550, the processing system 420 determines if all electrode configurations for the respective site are complete and if not returns to step 520. In this instance a next electrode configuration is selected, with steps 520 to 550 being repeated for this next electrode configuration. This process can then be repeated until each of the four electrode configurations shown in
Whilst it is possible to use all four of the indicated electrode configurations for the tetrapolar configuration, this is not essential, and in some circumstances, it is sufficient to use any two or more of the possible configurations. Thus, for example, the configurations used in
Furthermore, this arrangement can be used to provide a sequence of drive and measurement electrode configurations that can be used to perform multiple measurements at successive sites, with only a single drive and single measurement electrode being switched between successive measurements. An example of this is shown in
Once all the electrode configurations are complete for a specific site, the measuring device 400 or the computer system 420 is used to analyse the impedance values and determine if the impedance measurements are indicative of a tissue anomaly. As mentioned above this may be achieved in any one of a number of ways but typically involves examining the difference between measured impedance values. The reason for this is that the impedance measured at a given site should be substantially invariant irrespective of the electrode configuration used. Consequently, any variation in measured impedance values for different electrode configurations indicates that the tissue is non-uniform and in particular that there is likely to be a low impedance lesion situated between the drive electrodes D1, D2 and the measurement electrodes M1, M2.
In this regard, when the electrodes are provided in the arrangement of
For negative field region, a lower resistance than the surrounding tissue will result in an increase in measured impedance, whereas a lower resistance in the positive field region will result in a decrease in measured impedance. Example tissue electrical properties as given by Brown, B. H., Tidy, J. A., Boston, K., Blackett, A. D., Smallwood, R. H. and Sharp, F. (2000a). “Relation between tissue structure and imposed electrical current flow in cervical neoplasia,” The Lancet 355: 892-895, are shown in Table 1 below.
Thus, as cancerous tissue generally has a lower resistance, a cancerous lesion between the drive electrodes D1, D2 or between the measurement electrodes M1, M2 will result in a decreased impedance measurement, whereas a lesion between the each pair of drive and measurement electrodes D1, M2 or M1, D2, will result in an increased impedance measurement.
It will therefore be appreciated that examining differences between impedance measurements with different electrode configurations can allow tissue anomalies such as lesions, to be detected.
In one example this is achieved by determining the difference between the impedance values determined using the different electrode configurations, at step 560. The maximum determined difference is then compared to a reference at step 570. The reference, which is typically previously determined and stored in memory of the measuring device 400 or the computer system 420, represents a threshold value so that if the difference between impedance values is greater than the reference, then this indicates that a tissue anomaly is present.
The reference can be determined in any one of a number of ways depending on the preferred implementation. For example, the reference may be determined by studying a number of healthy individuals (individuals without lesions or other biological anomalies) and/or unhealthy individuals (individuals with lesions or other anomalies) and calculating a range of variations between impedance values at a given site. This can be used to provide an indication of typical differences between impedance values for a healthy individual, thereby allowing a threshold to be established for tissue anomalies.
A further alternative is to derive the reference from previous measurements made for the respective individual. For example, if the individual undergoes a medical intervention, such as surgery, or the like, which may result in a lesion forming, then measurements can be made for the individual prior to the intervention, or following initial development of the lesion. This can be used to establish a baseline of differences in impedance values for the individual, either prior to the lesion forming, or following lesion formation. This baseline can then be used as a subject specific reference so that changes in the difference between the impedance values for the individual, can be used to monitor lesion development and/or effectiveness of treatment.
A further option is to determine the reference using a statistical analysis of measurements made for a number of different sites. This could be performed by examining the mean difference for a number of sites over a region, and then calculating the reference based on a value that is a number of standard deviations from the mean. Accordingly, in this instance, an anomaly is identified if the difference for a site is more than a set number of standard deviations from the mean difference value for a number of sites.
In any event, if the reference is exceeded and the result is determined to be indicative of a tissue anomaly at step 580, then the site is identified as a tissue anomaly at step 590, in which case an appropriate indicator can be generated. The indicator could be indicative of the difference, the measured impedance values, impedance parameters, or the like. Alternatively, the indicator could be indicative of the result of the comparison, such as a colour indication indicating the presence or absence of a lesion, tumour or other anomaly. Thus, in one example, the probe can include indicator lights, allowing the indication to be provided. Alternatively, output may be via a display, or the like.
Once this is completed or otherwise, at step 600 the computer system 420 will determine if all sites are complete and if not will return to step 510 to select the next site in the electrode array 430. This will typically involve using the electrodes 631C, 631D and two electrodes in the next column in the array.
This process can be repeated for all of the sites defined by the electrode array 630, allowing an impedance map to be generated at 610. An indicator in the form of an impedance map can be used to indicate variations in tissue properties, or the like, which in turn can be used for a number of purposes, such as to monitor healing of wounds, or to allow anomalies to be identified, or the like.
As will be appreciated by persons skilled in the art, being able to identify, and subsequently discount or otherwise account for such tissue anomalies allows improved results to be obtained for impedance mapping processes.
Furthermore, this process can also be used to identify and monitor low impedance lesions, tumours or the like. For example, determining the magnitude of the difference between different impedance values obtained for a given site allows an indication of the severity of the lesion to be determined. By monitoring changes in the difference over time, this allows variations in lesion severity over time to be monitored.
Specific example trials of the process of performing impedance mapping will now be described.
The blood for each trial was collected from the same animal and treated with 70 mg/L of heparine to prevent coagulation. Blood for each measurement was prepared in the same manner by allowing it to cool to room temperature (22° C.) and the red blood cells separated via a centrifuge. The separated red blood cells and plasma could then be mixed in appropriate proportions to obtain the required haematocrit for testing. Samples were also collected and allowed to coagulate, these were used to represent a high impedance tissue medium at R0 due to the small extracellular space.
In a first example, impedance maps were initially established for homogenous haematocrit in an in-vitro environment. To achieve this, bovine blood was used as the conductive medium, with impedance maps being obtained using homogenous samples with a range of haematocrit values (0, 20, 40, 60, 80%).
The impedance maps of R0 measured for blood samples of various haematocrit are shown in
A plot of mean R0 for each impedance map against haematocrit is shown in
In a second trial, the electrode array 430 was covered with plasma (haematocrit of 0%) and red blood cells (haematocrit of 100%) injected onto the corner of the electrode array, as shown for example in
An example of the bioimpedance map of an average value of R0 obtained for each site is shown at 1000 in
It is evident from the above examples that bioimpedance maps for haematocrit 0 to 80% result in reasonably consistent values of R0 (standard deviation<3%). The uniform measurements also demonstrate that the remaining 21 electrodes have little effect on the measurements from the 4 electrodes actively involved. Hence these 21 electrodes do not shunt the current between the active drive electrodes.
The bioimpedance map of plasma with introduced cells clearly shows an increase in R0 at the site of the introduced cells, shown in
As shown in this example, the values of R0 determined for the site 1005 differ significantly for the four different orientations, thereby indicating the presence of a biological anomaly at the site 1005.
In this example, the sensitivity region between the two electrodes 431B, 431D is positive for the maps 1002, 1004 resulting in an increased measured impedance if a higher impedance medium is present between the electrodes. This increase in impedance is clearly seen in the maps 1002, 1004. The maps 1001, 1003 on the left show a decrease in impedance because the region between the two electrodes 431B, 431D is of negative sensitivity in this configuration, thereby resulting in a decreased measured impedance when a higher impedance medium is located in the region.
When performing an impedance analysis, the can be taken into account by excluding this site from the larger impedance map, allowing an accurate average to be determined that excludes any anomaly. Alternatively different mechanisms may be used for taking this into account. For example, averaging of the four measured values of R0, at the given site, can reduce the impact of the tissue anomaly. In this regard, the averaged impedance map would be unaffected since the higher and lower measured impedance values effectively average to cancel each other out, so that the R0 value in this region of the larger map is not anomalous.
Alternatively, the impedance of adjacent sites can be used to determine a value for R0 which is unaffected by the tissue anomaly. Thus, for example, examination of the maps 1001, 1002, 1003, 1004 for each tetrapolar configuration highlights that the determined impedance values determined for the site 1005 in the maps 1001, 1003 are similar to those of adjacent sites, whereas the impedance values determined for the site 1005 in the maps 1002, 1004 are significantly different. This implies that the lesion or other tissue anomaly is located between the drive and measurement electrodes for the electrode configurations used in determining the maps 1002, 1004, meaning that these readings are erroneous. Consequently, the impedance value used for the overall impedance map could be based on the impedance values determined for the impedance maps 1001, 1003 as these readings are more likely to be accurate.
This can be performed for example to discount readings that are believed to be anomalous, for example due to errors in the measuring process, poor electrode contact, or the like.
However, more typically the results are used to detect tissue anomalies, such as lesions or the like. Thus, as measurements made using orthogonal electrode orientations at a region of non-homogeneity will produce different measured impedances, whereas a region of homogeneity will produce the same measurements. This allows tissue anomalies, such as lesions, to be identified, and furthermore allows lesion boundaries to be determined.
An example of this will now be described with reference to
In this example, a region 1101 is highlighted which has low positive values of R0, where dispersed blood is present, and this is due to different haematocrits being located under each of these electrode sets. Within this region, the site 1102 has an R0 value of zero due to a high but homogeneous haematocrit sample being located under the electrode set.
In an upper right region 1103 of the impedance map, the average R0 values are close to zero due to the sample under the electrode sets being homogeneous plasma, the red blood cells having not dispersed into this region.
At the site 1105, a large negative value of R0 is present, implying the presence of a tissue anomaly or lesion. The site 1106 is also negative, but not to such a degree. This implies that a tissue anomaly is likely to be present at the site 1105 and that this may extend slightly into the site 1106. Accordingly, it will be appreciated that this not only allows tissue anomalies to be identified, but also allows the extent and/or boundaries of the tissue anomaly to be determined.
In a third example, a clot was introduced to the plasma in place of the red blood cells.
In
It will therefore be appreciated that the above described methods provide techniques for identifying the presence, absence and even extent of tissue anomalies, such as lesions. These anomalies did not appear to alter the resultant impedance map once averaged, meaning that the averaging of results prevents the tissue anomalies being detected. However, this does mean that even in the event that anomalies exist, this avoids the need to remove and discard such measurements.
Thus, the above described techniques provide a non-subjective method for determining lesion size and hence possible biopsy margins.
Notably, by using an electrode array coupled to a suitable switching system, this allows measurements to be rapidly performed over an area of the subject. Furthermore, by using only two measurements at each site, this can reduce the number of measurements required at each region and minimise the time taken to acquire an impedance map.
Further features will now be described.
In this regard, the accuracy of the measurement of impedance can be subject to a number of external factors. These can include, for example, the effect of capacitive coupling between the subject and the surrounding environment, the leads and the subject, the electrodes, or the like, which will vary based on factors such as lead construction, lead configuration, subject position, or the like. Additionally, there are typically variations in the impedance of the electrical connection between the electrode surface and the skin (known as the “electrode impedance”), which can depend on factors such as skin moisture levels, melatonin levels, or the like. A further source of error is the presence of inductive coupling between different electrical conductors within the leads, or between the leads themselves.
Such external factors can lead to inaccuracies in the measurement process and subsequent analysis and accordingly, it is desirable to be able to reduce the impact of external factors on the measurement process.
A specific example of the functionality implemented by the processing system 102 will now be described with reference to
In this example the processing system 102 includes a timing and control module 1300, an interface module 1301, an analysis module 1302, sine wave look up tables (LUTs) 1303, 1304, a current module 1305, and a voltage module 1306.
A number of analogue to digital converters (ADCs) 1327A, 1327B, 1328A, 1328B and digital to analogue converters (DACs) 1329A, 1329B are provided for coupling the processing system 102 to two signal generators 111A, 111B, one of which is provided for each of the drive electrodes, and two sensors 112A, 112B one of which is provided for each of the sense electrodes, as will be described in more detail below.
The signal generators 111A, 111B, and the two sensors 112A, 112B are coupled to the electrodes 113, 114, 115, 116 via the switching device 118, which is in turn connected to the timing and control module 1300. This arrangement allows the timing and control module 1300 to selectively interconnect the signal generators 111A, 111B, the two sensors 112A, 112B and the electrodes 113, 114, 115, 116, allowing different electrode configurations to be provided.
In use, the timing and control module 1300 determines the measurements to be performed, typically in accordance with input commands received from the input 105 via the interface module 1301 and uses this information to access the LUTs 1303, 1304, which in turn cause a digital sine wave signal to be produced based on the specified frequency and amplitude. The digital control signals are transferred to the DAC's 1329A, 1329B, to thereby allow analogue control signals indicative of the voltage drive signals VDA, VDB to be produced.
Measured analogue voltage and current signals VSA, VSB, ISA, ISB are digitised by the ADC's 1327, 1328 and provided to the current and voltage modules 1305, 1306. This allows the processing system 102 to determine the current flow by having the current module 1305 determine the total current flow through the subject using the two current signals ISA, ISB, with an indication of this being provided to the analysis module 1302. The voltage module 1306, which is typically in the form of a differential voltage amplifier, or the like, operates to determine a differential voltage, which is also transferred to the analysis module 1302, allowing the analysis module to determine impedance values using the current and differential voltage signals.
The control module 1300 may also be coupled to a fault detection module 1308. This monitors the magnitude of signals applied to the subject to determine if these are within acceptable threshold levels. If not, the fault detection module 1308 can cause the process to be halted or to allow an alert to be generated.
An example of the process for performing impedance measurements for lesion detection, will now be described with reference to
At step 1400 an impedance measurement type is selected, with the processing system 102 selecting a next measurement frequency fi, at step 1405. Following this, at step 1410, the processing system 102 determines an electrode configuration for a first measurement at a site, and configures the switching device 118 accordingly, so that the signal generators 111A, 111B, and the sensors 112A, 112B are connected to the electrodes 113, 114, 115, 116 as required.
At step 1415, the processing system 102 generates a sequence of digital voltage control signals. The digital control signals are converted to analogue control signals indicative of the voltage drive signals VDA, VDB using the DACs 1329A, 1329B at step 1420, allowing the analogue control signals to be provided to each of the signal generators 111A, 111B at step 1425. This causes each signal generator 111A, 111B to generate respective voltage drive signals VDA, VDB and apply these to the subject S at step 1430, via the switching device 118 and selected ones of the electrodes 113, 114, 115, 116 acting as drive electrodes.
At step 1435 the voltage induced across the subject is determined by having the sensors 112A, 112B sense voltages VSA, VSB at other selected ones of electrodes 113, 114, 115, 116, acting as sense electrodes. Thus, for example, if the electrodes 113, 114 are acting as drive electrodes, the electrodes 115, 116 will act as sense electrodes.
The sensed voltage signals VSA, VSB are digitised by the corresponding ADCs 1327A, 1327B at step 1440. At step 1445 current signals ISA, ISB, caused by application of the voltage drive signals VDA, VDB, are determined using the signal generators 111A, 111B, with an indication of the current signals ISA, ISB being transferred to the ADCs 1328A, 1328B for digitisation at step 1450.
At step 1455 the digitised current and voltage signals ISA, ISB, VSA, VSB are received by the processing system 102 allowing the processing system 102 to determine the magnitude of the applied current IS at step 1460. This may be performed using the current addition module 1305 in the above described functional example of
This situation may arise, for example, if the device is functioning incorrectly, or there is a problem with connections of electrodes to the subject, such as if one is not in correct electrical contact with the subject's skin or tissue. Accordingly, the alert can be used to trigger a device operator to check the electrode connections and/or device operation to allow any problems to be overcome. It will be appreciated, that any suitable form of corrective action may be taken such as attempting to restart the measurement process, reconnecting the electrodes to the subject S, reducing the magnitude of the current through the subject, or the like.
At step 1480, the processing system 102 operates to determine the differential voltage sensed across the subject. In the functional example described above with respect to
At step 1490, the processing system determines if all required electrode configurations have been analysed. Thus, as described above, it is typical to perform multiple measurements at a given site using a different electrode configuration, and in particular a different combination of drive and sense electrodes. If the required configurations have not been completed, then the process returns to step 1410, allowing the processing system 102 to reconfigure the switching device 118, allowing a different electrode configuration to be implemented.
Thus, for example, if initially the electrodes 113, 114 are acting as drive electrodes, and the electrodes 115, 116 are acting as sense electrodes, then the switching device 118 is reconfigured to provide an alternative configuration, such as having the electrodes 113, 115 act as drive electrodes, and the electrodes 114, 116 act as sense electrodes, allowing the process to be repeated at the different configuration.
If all required configurations have been tried, then at step 1495, it is determined if measurements at each of the frequencies have been performed, and if not, the process may return to step 1405 to allow the process to be repeated at a next measurement frequency fi. It will be appreciated that the use of multiple frequencies may only be required in some circumstances, such as if BIS is being performed, and may not be required in all examples.
Once all required frequencies are complete, at step 1500 the processing system 102 to analyse the impedance measurements, and determine the presence, absence of degree of any anomaly, as described above.
It will be appreciated that in the above example, multiple measurements may be performed at a given site. However, additionally measurements may also be performed over multiple sites, assuming the device 130 has sufficient electrodes to allow this to be performed.
In any event, the above described process this allows a number of impedance measurements to be performed using different electrode configurations, thereby allowing the detection of anomalies, such as lesions, using the techniques outlined above.
An example of the configuration of the signal generator and sensor for a single one of the channels, will now be described with reference to
The apparatus incorporates a substrate 1550, such as a printed circuit board (PCB), or the like, having the respective signal generator 111 and sensor 112 mounted thereon. The general functionality of the signal generator 111 and sensor 112 are represented by the components shown. In practice a greater number of components may be used in a suitable arrangement, as would be appreciated by persons skilled in the art, and the components shown are merely intended to indicate the functionality of the signal generator and the sensor 111, 112.
The substrate 1550 and associated components may be provided in a suitable housing, such as the handle portion 132 of the probe 130, to protect them during use, as will be appreciated by persons skilled in the art.
The signal generator 111 and the sensor 112 are coupled via respective cables 1561, 1562 to the switching device 118, and it will be appreciated from this that in practice a second signal generator 111 and second sensor 112, having a similar configuration, would also be provided. The switching device, is then coupled to the electrodes 113, 114, 115, as required.
In this example, the signal generator 111 includes an amplifier A1 having an input coupled to a connection 1551. The input is also coupled to a reference voltage, such as ground, via a resistor R1. An output of the amplifier A1 is connected via a resistor R2, to a switch SW, which is typically a CMOS (complementary metal-oxide semiconductor) switch or a relay that is used to enable the voltage source. The switch SW is controlled via enabling signals EN received from the processing system 102 via a connection 1552.
The switch SW is in turn coupled via two resistors R3, R4, arranged in series, and then, via the connection 1561, to the conductive pad 1563. A second amplifier A2 is provided with inputs in parallel with the first of the two series resistor R3 and with an output coupled via a resistor R5, to a connection 1553.
It will be appreciated from the above that the connections 1551, 1552, 1553 therefore forms the lead 123 of
The sensor 111 generally includes an amplifier A3 having an input connected via a resistor R6, to the connection 1562. The input is also coupled via a resistor R7, to a reference voltage such as a ground. An output of the amplifier A3 is coupled to a connection 954, via a resistor R7.
It will be appreciated from the above that the connection 1554 therefore forms the lead 125 of
Optional power connections 1555 can be provided for supplying power signals +Ve, −Ve, for powering the signal generator 111 and the sensor 112, although alternatively an on board power source such as a battery, may be used. Additionally, a connection 1556 may be provided to allow an LED 1557 to be provided on the substrate 1550. This can be controlled by the processing system 102, allowing the operating status of the signal generator and sensor to be indicated.
Operation of the signal generator 111 and the sensor 112 will now be described in more detail. For the purpose of this explanation, the voltage drive signal, current signal and sensed voltage will be generally indicated as VD, IS, VS, and in practice, these would be equivalent to respective ones of the voltage drive signals, current signals and sensed voltages VDA, VDB, ISA, ISB, VSA, VSB in the example above.
In use, the amplifier A1 operates to amplify the analogue voltage signal received from the DAC 1329 and apply this to the subject S via the connection 1561, so that the applied voltage drive signal VD drives a current signal IS through the subject S. The voltage drive signal VD, will only be applied if the switch SW is in a closed position and the switch SW can therefore be placed in an open position to isolate the voltage source from the subject S. This may be used if a pair of drive and sense electrodes 113, 115 are being used to sense voltages only, and are not being used to apply a voltage drive signal VD to the subject S. Isolating the signal generator 111 from the drive electrode 113 removes the unintended return current path(s) that would otherwise be present due to the low output impedance of the amplifier A1, thereby constraining current to flow only between the two selected drive electrodes 113. Other techniques may be used to achieve a similar effect, such as using an amplifier incorporating a high impedance output-disable state.
The current signal IS being applied to the subject S is detected and amplified using the amplifier A2, with the amplified current signal IS being returned to the processing system 102, along the connection 1553 and via the ADC 1328.
Similarly, the sensor 112 operates by having the amplifier A3 amplify the voltage detected at the second electrode 115, returning the amplified analogue sensed voltage signal VS along the connection 1554, to the ADC 1327.
Another potential source of error in impedance measurement processes is caused by cross electrode capacitive coupling. As shown in
To cancel the cross electrode capacitive coupling a cross electrode capacitance cancelling circuit is provided, as shown in
In this example, the impedances of each electrode 113, 115 and the subject S are represented by respective impedances Z113, Z115, ZS, formed by respective resistor and capacitor arrangements.
The cross electrode capacitance cancelling circuit 1570 is coupled to the output of the drive amplifier A1 and the input of the sense amplifier A3, and includes an inverting amplifier A4, having an input coupled to the output of the drive amplifier A1 and optionally in a differential arrangement to the input of sense amplifier A3. The output of the inverting amplifier is connected in series via a resistor R10 and a capacitor C10, to the input of the sense amplifier A3.
In one example, any signal output from the drive amplifier A1 will be inverted and then applied to the input of the sense amplifier A3. By selecting appropriate values for the resistor R10 and a capacitor C10, this allows the inverted signal to have a magnitude equal to the magnitude of any signal resulting from the effective cross electrode capacitance CDS.
In the differential example, the arrangement takes into account the fact that the magnitude of any leakage current between the electrodes is related to the magnitude of the cross electrode capacitance CDS and the voltage across it. Accordingly, the differential arrangement can take this into account by applying a voltage to the capacitor C10 which is the same amount above the input of sense amplifier A3 as the output of the drive amplifier A1 is below it.
However, it will be appreciated that the non differential arrangement can be used as this provides a suitable approximation to the differential approach, particularly if appropriate values are selected for the resistor R10 and a capacitor C10.
In one example, the resistance and/or capacitance of the resistor R10 and capacitor C10 respectively, can be adjusted, through the use of suitable adjustable components, such as a variable resistor or capacitor. This allows the magnitude and/or phase of the inverted signal to be controlled so that it effectively cancels the signal resulting from the effective cross electrode capacitance CDS. It will be appreciated that adjustment of the components may be performed during a calibration process, which will typically include the complete electrode unit together with its associated electrodes attached so that all parasitic capacitances are accurately represented.
Accordingly, the cross electrode capacitance cancelling circuit 1570 provides an effective negative capacitance between the drive electrode 113 and corresponding sense electrode 115, so that a negative current flow occurs, thereby cancelling the parasitic current. This therefore negates the effect of any capacitive coupling between the drive and sense electrodes 113, 115.
The apparatus may also include an input capacitance cancelling circuit, an example of which is shown in
In use, the sense electrodes 115 can capacitively couple to the environment, which results in an effective input capacitance CEI at the input of the sense amplifier A3. The effective capacitance allows signal leakage from the input of the sense amplifier to ground, thereby reducing the signal available at the amplifier input.
Accordingly, in this example, an input capacitance cancelling circuit 1580 is provided which connects the positive amplifier input of the sense amplifier A3 to the output of the sense amplifier, via a resistor R11 and a capacitor C11. This acts as a positive feedback loop, allowing a proportion of the amplified signal to be returned to the amplifier input. This acts to cancel the reduction in signal at the amplifier input that is caused by the effective input capacitance CEI, and therefore provides an effective negative capacitance that cancels the effect of the effective input capacitance CEI at the amplifier input. Again, the input capacitance cancelling circuit requires tuning, which can be achieved during calibration by suitable adjustment of the values of the resistor R11 and/or the capacitor C11.
As briefly mentioned above, when separate connections 123, 125, are used for the voltage signal VS and the current signal IS, then inductive coupling between the leads 123, 125 can result in EMFs being induced within the leads 123, 125. The magnitude of the EMF is dependent on the degree of coupling between the leads 123, 125 and hence their physical separation, and also increases in proportion to the frequency and amplitude of the current signal IS. The EMF induced within the leads 123, 125 results in an effective EMF across the input of the sensor 118. As a result, a component of the sensed voltage signal VS is due to the induced EMF, which in turn leads to inaccuracies in the determined voltage signal VS and the current signal IS.
The effect of inductive coupling varies depending on the physical separation of the leads 123, 125. Accordingly, in one example, the effect of inductive coupling between leads can be reduced by physically separating the connections 1551, 1552, 1553, 1554, 1555, 1556 as much as possible.
Additionally, as the physical arrangement of connections within the device will be constant any EMF induced along the connections is also substantially constant, allowing this to be accounted for during a calibration process.
Accordingly, when the apparatus 100/130 is initially configured, and in particular, when the algorithms are generated for analysing the voltage and current signals VS, IS, to determine impedance measurements, these can include calibration factors that take into account the induced EMF. In particular, during the configuration process, an apparatus 100/130 can be used to take measurements from reference impedances, with the resulting calculations being used to determine the effect of the induced EMF, allowing this to be subtracted from future measurements.
Persons skilled in the art will appreciate that numerous variations and modifications will become apparent. All such variations and modifications which become apparent to persons skilled in the art, should be considered to fall within the spirit and scope that the invention broadly appearing before described.
Thus, for example, it will be appreciated that features from different examples above may be used interchangeably where appropriate. Furthermore, whilst the above examples have focussed on a subject such as a human, it will be appreciated that the measuring device and techniques described above can be used with any subject such as an animal, including but not limited to, primates, livestock, performance animals, such race horses, or the like, as well as to in-vitro samples, or the like.
The above described processes can be used for determining the health status of an individual, including determining the presence, absence or degree of a range of biological anomalies. It will be appreciated from this that whilst the above examples use the term lesion, this is for the purpose of example only and is not intended to be limiting.
Furthermore, whilst the above described examples have focussed on the application of a current signal to allow a voltage to be measured, this is not essential and the process can also be used when applying a voltage signal to allow a current to be sensed.
The above described impedance maps are determined based on the value of the impedance parameter R0. However, it will be appreciated that impedance maps based on other impedance parameters, such as actual measured impedances, or values of R∞, Zc, or the like.
Whilst the above described techniques have focused on the detection of lesions and other anomalies in the cervix, it will be appreciated that the above described techniques can be used for detecting lesions in a range of situations, and can therefore also be used in the diagnosis of prostate cancer, or the like. The detection of lesions can also be used in cancer screening, as well as in the triage of abnormal cytology or a HPV high risk genotype positive result.
| Number | Date | Country | Kind |
|---|---|---|---|
| 2008906169 | Nov 2008 | AU | national |
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/AU2009/001553 | 11/27/2009 | WO | 00 | 7/26/2011 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2010/060152 | 6/3/2010 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 3316896 | Thomasset | May 1967 | A |
| 3834374 | Ensanian et al. | Sep 1974 | A |
| 3851641 | Toole et al. | Dec 1974 | A |
| 3871359 | Pacela | Mar 1975 | A |
| 4008712 | Nyboer | Feb 1977 | A |
| 4034854 | Bevilacqua | Jul 1977 | A |
| 4144878 | Wheeler | Mar 1979 | A |
| RE30101 | Kubicek et al. | Sep 1979 | E |
| 4184486 | Papa | Jan 1980 | A |
| 4291708 | Frei et al. | Sep 1981 | A |
| 4314563 | Wheeler | Feb 1982 | A |
| 4353372 | Ayer | Oct 1982 | A |
| 4365634 | Bare et al. | Dec 1982 | A |
| 4401356 | Bare | Aug 1983 | A |
| 4407288 | Langer et al. | Oct 1983 | A |
| 4407300 | Davis | Oct 1983 | A |
| 4450527 | Sramek | May 1984 | A |
| 4458694 | Sollish et al. | Jul 1984 | A |
| 4486835 | Bai et al. | Dec 1984 | A |
| 4537203 | Machida | Aug 1985 | A |
| 4539640 | Fry et al. | Sep 1985 | A |
| 4557271 | Stoller et al. | Dec 1985 | A |
| 4583549 | Manoli | Apr 1986 | A |
| 4602338 | Cook | Jul 1986 | A |
| 4617939 | Brown et al. | Oct 1986 | A |
| 4638807 | Ryder | Jan 1987 | A |
| 4646754 | Seale | Mar 1987 | A |
| 4686477 | Givens et al. | Aug 1987 | A |
| 4688580 | Ko et al. | Aug 1987 | A |
| 4695955 | Faisandier | Sep 1987 | A |
| 4763660 | Kroll et al. | Aug 1988 | A |
| 4793362 | Tedner | Dec 1988 | A |
| 4832608 | Kroll | May 1989 | A |
| 4890630 | Kroll et al. | Jan 1990 | A |
| 4895163 | Libke et al. | Jan 1990 | A |
| 4905705 | Kizakevich et al. | Mar 1990 | A |
| 4911175 | Shizgal | Mar 1990 | A |
| 4924875 | Chamoun | May 1990 | A |
| 4942880 | Slovak | Jul 1990 | A |
| 4951682 | Petre | Aug 1990 | A |
| 5025784 | Shao et al. | Jun 1991 | A |
| 5063937 | Ezenwa et al. | Nov 1991 | A |
| 5078134 | Heilman et al. | Jan 1992 | A |
| 5086781 | Bookspan | Feb 1992 | A |
| 5101828 | Welkowitz et al. | Apr 1992 | A |
| 5143079 | Frei et al. | Sep 1992 | A |
| 5197479 | Hubelbank et al. | Mar 1993 | A |
| 5199432 | Quedens et al. | Apr 1993 | A |
| 5246008 | Mueller | Sep 1993 | A |
| 5280429 | Withers | Jan 1994 | A |
| 5305192 | Bonte et al. | Apr 1994 | A |
| 5309917 | Wang et al. | May 1994 | A |
| 5311878 | Brown et al. | May 1994 | A |
| 5372141 | Gallup et al. | Dec 1994 | A |
| 5415164 | Faupel et al. | May 1995 | A |
| 5421344 | Popp | Jun 1995 | A |
| 5423326 | Wang et al. | Jun 1995 | A |
| 5449000 | Libke et al. | Sep 1995 | A |
| 5454377 | Dzwonczyk et al. | Oct 1995 | A |
| 5465730 | Zadehkoochak et al. | Nov 1995 | A |
| 5469859 | Tsoglin et al. | Nov 1995 | A |
| 5503157 | Sramek | Apr 1996 | A |
| 5505209 | Reining | Apr 1996 | A |
| 5511553 | Segalowitz | Apr 1996 | A |
| 5526808 | Kaminsky | Jun 1996 | A |
| 5529072 | Sramek | Jun 1996 | A |
| 5544662 | Saulnier et al. | Aug 1996 | A |
| 5557242 | Wetherell | Sep 1996 | A |
| 5562607 | Gyory | Oct 1996 | A |
| 5588429 | Isaacson et al. | Dec 1996 | A |
| 5596283 | Mellitz et al. | Jan 1997 | A |
| 5626146 | Barber et al. | May 1997 | A |
| 5679022 | Cappa et al. | Oct 1997 | A |
| 5704355 | Bridges | Jan 1998 | A |
| 5718231 | Dewhurst et al. | Feb 1998 | A |
| 5732710 | Rabinovich et al. | Mar 1998 | A |
| 5735284 | Tsoglin et al. | Apr 1998 | A |
| 5746214 | Brown et al. | May 1998 | A |
| 5759159 | Masreliez | Jun 1998 | A |
| 5788643 | Feldman | Aug 1998 | A |
| 5800350 | Coppleson et al. | Sep 1998 | A |
| 5807251 | Wang et al. | Sep 1998 | A |
| 5807270 | Williams | Sep 1998 | A |
| 5807272 | Kun et al. | Sep 1998 | A |
| 5810742 | Pearlman | Sep 1998 | A |
| 5876353 | Riff | Mar 1999 | A |
| 5906614 | Stern et al. | May 1999 | A |
| 5919142 | Boone et al. | Jul 1999 | A |
| 5957861 | Combs et al. | Sep 1999 | A |
| 6006125 | Kelly et al. | Dec 1999 | A |
| 6011992 | Hubbard et al. | Jan 2000 | A |
| 6015389 | Brown | Jan 2000 | A |
| 6018677 | Vidrine et al. | Jan 2000 | A |
| 6026323 | Skladnev et al. | Feb 2000 | A |
| 6122544 | Organ | Sep 2000 | A |
| 6125297 | Siconolfi | Sep 2000 | A |
| 6142949 | Ubby | Nov 2000 | A |
| 6151520 | Combs | Nov 2000 | A |
| 6151523 | Rosell Ferrer et al. | Nov 2000 | A |
| 6173003 | Whikehart et al. | Jan 2001 | B1 |
| 6208890 | Sarrazin et al. | Mar 2001 | B1 |
| 6228033 | Koobi et al. | May 2001 | B1 |
| 6233473 | Shepherd et al. | May 2001 | B1 |
| 6236886 | Cherepenin et al. | May 2001 | B1 |
| 6248083 | Smith et al. | Jun 2001 | B1 |
| 6256532 | Cha | Jul 2001 | B1 |
| 6292690 | Petrucelli et al. | Sep 2001 | B1 |
| 6339722 | Heethaar et al. | Jan 2002 | B1 |
| 6354996 | Drinan et al. | Mar 2002 | B1 |
| 6432045 | Lemperle | Aug 2002 | B2 |
| 6469732 | Chang et al. | Oct 2002 | B1 |
| 6472888 | Oguma et al. | Oct 2002 | B2 |
| 6496725 | Kamada et al. | Dec 2002 | B2 |
| 6497659 | Rafert | Dec 2002 | B1 |
| 6511438 | Bernstein et al. | Jan 2003 | B2 |
| 6512949 | Combs et al. | Jan 2003 | B1 |
| 6532384 | Fukuda | Mar 2003 | B1 |
| 6551252 | Sackner et al. | Apr 2003 | B2 |
| 6556001 | Wiegand et al. | Apr 2003 | B1 |
| 6560480 | Nachaliel et al. | May 2003 | B1 |
| 6561986 | Baura et al. | May 2003 | B2 |
| 6569160 | Goldin et al. | May 2003 | B1 |
| 6584348 | Glukhovsky | Jun 2003 | B2 |
| 6602201 | Hepp et al. | Aug 2003 | B1 |
| 6615077 | Zhu et al. | Sep 2003 | B1 |
| 6618616 | Iijima et al. | Sep 2003 | B2 |
| 6623312 | Merry et al. | Sep 2003 | B2 |
| 6625487 | Herleikson | Sep 2003 | B2 |
| 6631292 | Liedtke | Oct 2003 | B1 |
| 6633777 | Szopinski | Oct 2003 | B2 |
| 6636754 | Baura et al. | Oct 2003 | B1 |
| 6643543 | Takehara et al. | Nov 2003 | B2 |
| 6714813 | Ishigooka et al. | Mar 2004 | B2 |
| 6714814 | Yamada et al. | Mar 2004 | B2 |
| 6723049 | Skladnev et al. | Apr 2004 | B2 |
| 6724200 | Fukuda | Apr 2004 | B2 |
| 6725089 | Komatsu et al. | Apr 2004 | B2 |
| 6753487 | Fujii et al. | Jun 2004 | B2 |
| 6760617 | Ward et al. | Jul 2004 | B2 |
| 6768921 | Organ et al. | Jul 2004 | B2 |
| 6788966 | Kenan | Sep 2004 | B2 |
| 6790178 | Mault et al. | Sep 2004 | B1 |
| 6807443 | Keren | Oct 2004 | B2 |
| 6829501 | Nielsen et al. | Dec 2004 | B2 |
| 6829503 | Alt | Dec 2004 | B2 |
| 6845264 | Skladnev et al. | Jan 2005 | B1 |
| 6870109 | Villarreal | Mar 2005 | B1 |
| 6906533 | Yoshida | Jun 2005 | B1 |
| 6922586 | Davies | Jul 2005 | B2 |
| 6980852 | Jersey-Willuhn et al. | Dec 2005 | B2 |
| 7096061 | Arad | Aug 2006 | B2 |
| 7122012 | Bouton et al. | Oct 2006 | B2 |
| 7130680 | Kodama et al. | Oct 2006 | B2 |
| 7148701 | Park et al. | Dec 2006 | B2 |
| 7149573 | Wang | Dec 2006 | B2 |
| 7164522 | Kimura et al. | Jan 2007 | B2 |
| 7169107 | Jersey-Willuhn et al. | Jan 2007 | B2 |
| 7184820 | Jersey-Willuhn et al. | Feb 2007 | B2 |
| 7184821 | Belalcazar et al. | Feb 2007 | B2 |
| 7186220 | Stahmann et al. | Mar 2007 | B2 |
| 7206630 | Tarler | Apr 2007 | B1 |
| 7212852 | Smith et al. | May 2007 | B2 |
| 7214107 | Powell et al. | May 2007 | B2 |
| 7233823 | Simond et al. | Jun 2007 | B2 |
| 7251524 | Hepp et al. | Jul 2007 | B1 |
| 7270580 | Bradley et al. | Sep 2007 | B2 |
| D557809 | Neverov | Dec 2007 | S |
| 7353058 | Weng et al. | Apr 2008 | B2 |
| 7390303 | Dafni | Jun 2008 | B2 |
| 7457660 | Smith et al. | Nov 2008 | B2 |
| 7477937 | Iijima et al. | Jan 2009 | B2 |
| D603051 | Causevic | Oct 2009 | S |
| 7706872 | Min et al. | Apr 2010 | B2 |
| 7733224 | Tran | Jun 2010 | B2 |
| 7749013 | Sato et al. | Jul 2010 | B2 |
| 7907997 | Stahmann et al. | Mar 2011 | B2 |
| D641886 | Causevic | Jul 2011 | S |
| D647208 | Rothman | Oct 2011 | S |
| D669186 | Gozani | Oct 2012 | S |
| D669187 | Gozani | Oct 2012 | S |
| D674096 | Gaw | Jan 2013 | S |
| 8467865 | Gregory | Jun 2013 | B2 |
| D718458 | Vosch | Nov 2014 | S |
| D719660 | Vosch | Dec 2014 | S |
| D728801 | Machon | May 2015 | S |
| 20010007056 | Linder et al. | Jul 2001 | A1 |
| 20010007924 | Kamada et al. | Jul 2001 | A1 |
| 20010020138 | Ishigooka et al. | Sep 2001 | A1 |
| 20010021799 | Ohlsson | Sep 2001 | A1 |
| 20010025139 | Pearlman | Sep 2001 | A1 |
| 20010049479 | Szopinski | Dec 2001 | A1 |
| 20010051774 | Littrup et al. | Dec 2001 | A1 |
| 20020022787 | Takehara et al. | Feb 2002 | A1 |
| 20020035334 | Meij | Mar 2002 | A1 |
| 20020072682 | Hopman et al. | Jun 2002 | A1 |
| 20020072686 | Hoey et al. | Jun 2002 | A1 |
| 20020079910 | Fukuda | Jun 2002 | A1 |
| 20020093992 | Plangger | Jul 2002 | A1 |
| 20020109621 | Khair et al. | Aug 2002 | A1 |
| 20020111559 | Kurata | Aug 2002 | A1 |
| 20020123694 | Organ et al. | Sep 2002 | A1 |
| 20020138019 | Wexler et al. | Sep 2002 | A1 |
| 20020161311 | Ward et al. | Oct 2002 | A1 |
| 20020163408 | Fujii et al. | Nov 2002 | A1 |
| 20020194419 | Rajput et al. | Dec 2002 | A1 |
| 20030004403 | Drinan et al. | Jan 2003 | A1 |
| 20030004433 | Hirschman | Jan 2003 | A1 |
| 20030023184 | Pitts-Crick et al. | Jan 2003 | A1 |
| 20030028221 | Zhu et al. | Feb 2003 | A1 |
| 20030050570 | Kodama | Mar 2003 | A1 |
| 20030068914 | Merry et al. | Apr 2003 | A1 |
| 20030073916 | Yonce | Apr 2003 | A1 |
| 20030105411 | Smallwood et al. | Jun 2003 | A1 |
| 20030120170 | Zhu et al. | Jun 2003 | A1 |
| 20030120182 | Wilkinson et al. | Jun 2003 | A1 |
| 20030173976 | Wiegand et al. | Sep 2003 | A1 |
| 20030216661 | Davies | Nov 2003 | A1 |
| 20030216664 | Suarez | Nov 2003 | A1 |
| 20040015095 | Li et al. | Jan 2004 | A1 |
| 20040019292 | Drinan et al. | Jan 2004 | A1 |
| 20040054298 | Masuo et al. | Mar 2004 | A1 |
| 20040059242 | Masuo et al. | Mar 2004 | A1 |
| 20040073127 | Istvan et al. | Apr 2004 | A1 |
| 20040073130 | Bohm et al. | Apr 2004 | A1 |
| 20040077944 | Steinberg et al. | Apr 2004 | A1 |
| 20040116819 | Alt | Jun 2004 | A1 |
| 20040158167 | Smith et al. | Aug 2004 | A1 |
| 20040167423 | Pillon et al. | Aug 2004 | A1 |
| 20040171691 | Smith | Sep 2004 | A1 |
| 20040171961 | Smith et al. | Sep 2004 | A1 |
| 20040171963 | Takehara | Sep 2004 | A1 |
| 20040181164 | Smith et al. | Sep 2004 | A1 |
| 20040186392 | Ward et al. | Sep 2004 | A1 |
| 20040204658 | Dietz et al. | Oct 2004 | A1 |
| 20040210150 | Virtanen | Oct 2004 | A1 |
| 20040210158 | Organ et al. | Oct 2004 | A1 |
| 20040234113 | Miga | Nov 2004 | A1 |
| 20040236202 | Burton | Nov 2004 | A1 |
| 20040242989 | Zhu et al. | Dec 2004 | A1 |
| 20040252870 | Reeves et al. | Dec 2004 | A1 |
| 20040253652 | Davies | Dec 2004 | A1 |
| 20040260167 | Leonhardt et al. | Dec 2004 | A1 |
| 20040267344 | Stett et al. | Dec 2004 | A1 |
| 20050033281 | Bowman et al. | Feb 2005 | A1 |
| 20050039763 | Kraemer et al. | Feb 2005 | A1 |
| 20050070778 | Lackey et al. | Mar 2005 | A1 |
| 20050080460 | Wang et al. | Apr 2005 | A1 |
| 20050098343 | Fukuda | May 2005 | A1 |
| 20050101875 | Semler et al. | May 2005 | A1 |
| 20050107719 | Arad (Abbound) et al. | May 2005 | A1 |
| 20050113704 | Lawson et al. | May 2005 | A1 |
| 20050117196 | Kimura et al. | Jun 2005 | A1 |
| 20050124908 | Belalcazar et al. | Jun 2005 | A1 |
| 20050137480 | Alt et al. | Jun 2005 | A1 |
| 20050151545 | Park et al. | Jul 2005 | A1 |
| 20050177062 | Skrabal et al. | Aug 2005 | A1 |
| 20050192488 | Bryenton et al. | Sep 2005 | A1 |
| 20050192511 | Shiokawa | Sep 2005 | A1 |
| 20050201598 | Harel et al. | Sep 2005 | A1 |
| 20050203435 | Nakada | Sep 2005 | A1 |
| 20050203436 | Davies | Sep 2005 | A1 |
| 20050215918 | Frantz et al. | Sep 2005 | A1 |
| 20050228309 | Fisher et al. | Oct 2005 | A1 |
| 20050261743 | Kroll | Nov 2005 | A1 |
| 20050283091 | Kink et al. | Dec 2005 | A1 |
| 20060004300 | Kennedy | Jan 2006 | A1 |
| 20060041280 | Stahmann et al. | Feb 2006 | A1 |
| 20060047189 | Takehara | Mar 2006 | A1 |
| 20060064029 | Arad (Abboud) et al. | Mar 2006 | A1 |
| 20060085048 | Cory et al. | Apr 2006 | A1 |
| 20060085049 | Cory et al. | Apr 2006 | A1 |
| 20060100532 | Bae | May 2006 | A1 |
| 20060110962 | Powell et al. | May 2006 | A1 |
| 20060111652 | McLeod | May 2006 | A1 |
| 20060116599 | Davis | Jun 2006 | A1 |
| 20060122523 | Bonmassar et al. | Jun 2006 | A1 |
| 20060122540 | Zhu et al. | Jun 2006 | A1 |
| 20060128193 | Bradley et al. | Jun 2006 | A1 |
| 20060135886 | Lippert et al. | Jun 2006 | A1 |
| 20060151815 | Graovac et al. | Jul 2006 | A1 |
| 20060197509 | Kanamori et al. | Sep 2006 | A1 |
| 20060200033 | Keren et al. | Sep 2006 | A1 |
| 20060224079 | Washchuk | Oct 2006 | A1 |
| 20060224080 | Oku et al. | Oct 2006 | A1 |
| 20060241513 | Hatlestad et al. | Oct 2006 | A1 |
| 20060241719 | Foster et al. | Oct 2006 | A1 |
| 20060247543 | Cornish et al. | Nov 2006 | A1 |
| 20060247739 | Wahlstrand et al. | Nov 2006 | A1 |
| 20060258952 | Stahmann et al. | Nov 2006 | A1 |
| 20060264775 | Mills et al. | Nov 2006 | A1 |
| 20060264776 | Stahmann et al. | Nov 2006 | A1 |
| 20060270942 | McAdams | Nov 2006 | A1 |
| 20060293609 | Stahmann et al. | Dec 2006 | A1 |
| 20070007975 | Hawkins et al. | Jan 2007 | A1 |
| 20070010758 | Matthiessen et al. | Jan 2007 | A1 |
| 20070027402 | Levin et al. | Feb 2007 | A1 |
| 20070043303 | Osypka et al. | Feb 2007 | A1 |
| 20070049993 | Hofmann et al. | Mar 2007 | A1 |
| 20070087703 | Li et al. | Apr 2007 | A1 |
| 20070106342 | Schumann | May 2007 | A1 |
| 20070156061 | Hess | Jul 2007 | A1 |
| 20080001608 | Saulnier et al. | Jan 2008 | A1 |
| 20080002873 | Reeves et al. | Jan 2008 | A1 |
| 20080004904 | Tran | Jan 2008 | A1 |
| 20080009757 | Tsoglin et al. | Jan 2008 | A1 |
| 20080009759 | Chetham | Jan 2008 | A1 |
| 20080039700 | Drinan et al. | Feb 2008 | A1 |
| 20080064981 | Gregory | Mar 2008 | A1 |
| 20080205717 | Reeves et al. | Aug 2008 | A1 |
| 20080252304 | Woo et al. | Oct 2008 | A1 |
| 20080262375 | Brown et al. | Oct 2008 | A1 |
| 20080270051 | Essex et al. | Oct 2008 | A1 |
| 20080287823 | Chetham | Nov 2008 | A1 |
| 20080319336 | Ward et al. | Dec 2008 | A1 |
| 20090043222 | Chetham | Feb 2009 | A1 |
| 20090054952 | Glukhovsky et al. | Feb 2009 | A1 |
| 20090076343 | James et al. | Mar 2009 | A1 |
| 20090076345 | Manicka et al. | Mar 2009 | A1 |
| 20090076350 | Bly et al. | Mar 2009 | A1 |
| 20090082679 | Chetham | Mar 2009 | A1 |
| 20090084674 | Holzhacker et al. | Apr 2009 | A1 |
| 20090105555 | Dacso et al. | Apr 2009 | A1 |
| 20090143663 | Chetham | Jun 2009 | A1 |
| 20090177099 | Smith et al. | Jul 2009 | A1 |
| 20090264776 | Vardy | Oct 2009 | A1 |
| 20090287102 | Ward | Nov 2009 | A1 |
| 20090306535 | Davies et al. | Dec 2009 | A1 |
| 20090318778 | Dacso et al. | Dec 2009 | A1 |
| 20100100003 | Chetham et al. | Apr 2010 | A1 |
| 20100109739 | Ironstone et al. | May 2010 | A1 |
| 20100145164 | Howell | Jun 2010 | A1 |
| 20100168530 | Chetham et al. | Jul 2010 | A1 |
| 20100234701 | Cho et al. | Sep 2010 | A1 |
| 20110025348 | Chetham et al. | Feb 2011 | A1 |
| 20110060239 | Gaw | Mar 2011 | A1 |
| 20110118619 | Burton et al. | May 2011 | A1 |
| 20110251513 | Chetham | Oct 2011 | A1 |
| Number | Date | Country |
|---|---|---|
| 2231038 | Nov 1999 | CA |
| 2613524 | Jan 2007 | CA |
| 2615845 | Jan 2007 | CA |
| 2638958 | Nov 2011 | CA |
| 1180513 | May 1998 | CN |
| 1236597 | Dec 1999 | CN |
| 1329875 | Jan 2002 | CN |
| 1366694 | Aug 2002 | CN |
| 101385203 | Mar 2009 | CN |
| 2912349 | Oct 1980 | DE |
| 249823 | Dec 1987 | EP |
| 349043 | Jan 1990 | EP |
| 357309 | Mar 1990 | EP |
| 377887 | Jul 1990 | EP |
| 581073 | Feb 1994 | EP |
| 662311 | Jul 1995 | EP |
| 865763 | Sep 1998 | EP |
| 869360 | Oct 1998 | EP |
| 1078597 | Feb 2001 | EP |
| 1080686 | Mar 2001 | EP |
| 1112715 | Jul 2001 | EP |
| 1114610 | Jul 2001 | EP |
| 1146344 | Oct 2001 | EP |
| 1177760 | Feb 2002 | EP |
| 1219937 | Jul 2002 | EP |
| 1238630 | Sep 2002 | EP |
| 1247487 | Oct 2002 | EP |
| 1283539 | Feb 2003 | EP |
| 1329190 | Jul 2003 | EP |
| 1338246 | Aug 2003 | EP |
| 1452131 | Sep 2004 | EP |
| 1629772 | Mar 2006 | EP |
| 2486386 | Jan 1982 | FR |
| 2748928 | Nov 1997 | FR |
| 2131558 | Jun 1984 | GB |
| 2260416 | Apr 1993 | GB |
| 2426824 | Dec 2006 | GB |
| 04-096733 | Mar 1992 | JP |
| 06-000168 | Jan 1994 | JP |
| 8191808 | Jul 1996 | JP |
| 9051884 | Feb 1997 | JP |
| 9220209 | Aug 1997 | JP |
| 10000185 | Jan 1998 | JP |
| 10014898 | Jan 1998 | JP |
| 10014899 | Jan 1998 | JP |
| 10-080406 | Mar 1998 | JP |
| 10-225521 | Aug 1998 | JP |
| 11070090 | Mar 1999 | JP |
| 2000107138 | Apr 2000 | JP |
| 2000139867 | May 2000 | JP |
| 2001037735 | Feb 2001 | JP |
| 2001-070273 | Mar 2001 | JP |
| 2001061804 | Mar 2001 | JP |
| 2001-224568 | Aug 2001 | JP |
| 2001321352 | Nov 2001 | JP |
| 2002-350477 | Apr 2002 | JP |
| 2002-238870 | Aug 2002 | JP |
| 2002330938 | Nov 2002 | JP |
| 2003-230547 | Aug 2003 | JP |
| 2003-075487 | Dec 2003 | JP |
| 2004-61251 | Feb 2004 | JP |
| 2005099186 | Apr 2005 | JP |
| 2005-143786 | Jun 2005 | JP |
| 2008022995 | Feb 2008 | JP |
| 001019789 | Jul 2003 | NL |
| 2112416 | Jun 1998 | RU |
| 2138193 | Sep 1999 | RU |
| 1132911 | Jan 1985 | SU |
| 8807392 | Oct 1988 | WO |
| 9318821 | Sep 1993 | WO |
| 9410922 | May 1994 | WO |
| 9601586 | Jan 1996 | WO |
| 9612439 | May 1996 | WO |
| 9632652 | Oct 1996 | WO |
| 9711638 | Apr 1997 | WO |
| 9714358 | Apr 1997 | WO |
| 9724156 | Jul 1997 | WO |
| 9743000 | Nov 1997 | WO |
| 9806328 | Feb 1998 | WO |
| 9823204 | Jun 1998 | WO |
| 9833553 | Aug 1998 | WO |
| 9851211 | Nov 1998 | WO |
| 9854792 | Dec 1998 | WO |
| 0019886 | Apr 2000 | WO |
| 0040955 | Jul 2000 | WO |
| 0079255 | Dec 2000 | WO |
| 0127605 | Apr 2001 | WO |
| 0150954 | Jul 2001 | WO |
| 0167098 | Sep 2001 | WO |
| 0178831 | Oct 2001 | WO |
| 0182323 | Nov 2001 | WO |
| 0247548 | Jun 2002 | WO |
| 02-053028 | Jul 2002 | WO |
| 02062214 | Aug 2002 | WO |
| 02094096 | Nov 2002 | WO |
| 02100267 | Dec 2002 | WO |
| 2004000115 | Dec 2003 | WO |
| 2004-032738 | Apr 2004 | WO |
| 2004026136 | Apr 2004 | WO |
| 2004030535 | Apr 2004 | WO |
| 2004032738 | Apr 2004 | WO |
| 2004-043252 | May 2004 | WO |
| 2004-047636 | Jun 2004 | WO |
| 2004047635 | Jun 2004 | WO |
| 2004047636 | Jun 2004 | WO |
| 2004047638 | Jun 2004 | WO |
| 2004048983 | Jun 2004 | WO |
| 2004049936 | Jun 2004 | WO |
| 2004083804 | Sep 2004 | WO |
| 2004084723 | Oct 2004 | WO |
| 2004084724 | Oct 2004 | WO |
| 2004-098389 | Nov 2004 | WO |
| 2005010640 | Feb 2005 | WO |
| 2005018432 | Mar 2005 | WO |
| 2005027717 | Mar 2005 | WO |
| 2005051194 | Jun 2005 | WO |
| 2005084539 | Sep 2005 | WO |
| 2005122881 | Dec 2005 | WO |
| 2005122888 | Dec 2005 | WO |
| 2006129116 | Dec 2006 | WO |
| 2006129108 | Dec 2006 | WO |
| 2007002991 | Jan 2007 | WO |
| 2007002992 | Jan 2007 | WO |
| 2007002993 | Jan 2007 | WO |
| 2007009183 | Jan 2007 | WO |
| 2007014417 | Feb 2007 | WO |
| 2007041783 | Apr 2007 | WO |
| 2007-056493 | May 2007 | WO |
| 2007089278 | Aug 2007 | WO |
| 2008064426 | Jun 2008 | WO |
| 2008119166 | Oct 2008 | WO |
| 2008138062 | Nov 2008 | WO |
| 2009018620 | Feb 2009 | WO |
| 2009036369 | Mar 2009 | WO |
| 2009059351 | May 2009 | WO |
| 2009100491 | Aug 2009 | WO |
| 2010051600 | May 2010 | WO |
| 2010060152 | Jun 2010 | WO |
| 2011022068 | Feb 2011 | WO |
| 2011050393 | May 2011 | WO |
| 2011075769 | Jun 2011 | WO |
| Entry |
|---|
| Forslund et al., Evaluation of modified multicompartment models to calculate body composition in healthy males, Am. J. of Clin. Nutrition, 1996; 63: 856-62. |
| De Lorenzo et al.; Predicting body cell mass with bioimpedance by using theoretical methods: a technological review; J. Appl. Physiol., 1997; 82(5): 1542-58. |
| Zhu et al.; Segment-specific resistivity improves body fluid volume estimates from bioimpedance spectroscopy in hemodialysis patients; J. Appl. Physiol., 2005; 100: 717-724. |
| Liu et al.; Primary multi-frequency data analyze in electrical impedance scanning; Proceedings of the IEEE-EMBS 2005, 27th Annual Int'l Conference of the Engineering in Med. and Biology Soc., Shanghai, China, Sep. 4, 2005; 1504-1507. |
| Gudivaka et al.; Single- and multifrequency models for bioelectrical impedance analysis of body water compartments; J. Appl. Physiol., 1999; 87(3): 1087-96. |
| Thomas et al.; Bioimpedance Spectrometry in the determination of Body Water Compartments: Accuracy and Clinical Significance; Applied Radiation and Isotopes, Elsevier, Oxford, GB, 1998; 49(5-6): 447-455. |
| Cornish et al.; Data analysis in multiple-frequency bioelectrical impedance analysis; Physiological Measurement, Institute of Physics Publishing, Bristol, GB, 1998; 19(2): 275-283. |
| Ulgen et al.; Electrical Parameters of Human Blood; Database accession No. 6408967 & Proceedings of the 20th Annual International Conference of the IEEE Engineering in Medicine and Biology Soc., 1998; 20(6): 2983-2986, IEEE Piscataway, NJ. |
| Gerth et al., A computer-based bioelectrical impedance spectroscopic system for noninvasive assesment of compartmental fluid redistribution, 1990; 446-453. |
| Kanai et al.; Electrical measurement of fluid distribution in legs and arms; Medical Progress through Technology, 1987; 12: 159-170. |
| Bracco et al.; Bedside determination of fluid accumulation after cardiac surgery usign segmental bioelectrical impedance; Critical Care Medicine, 1998; 26(6): 1065-1070. |
| Chiolero et al.; Assessment of changes in body water by bioimpedance in acutely ill surgical patients; Intensive Care Medicine, 1992; 18: 322-326. |
| Chumlea et al.; Bioelectrical impedance and body composition: present status and future directions; Nutrition Reviews, 1994; 52(4): 123-131. |
| Cornish et al.; Bioelectrical impedance for monitoring the efficacy of lymphoedema treatment programmes; Breast Cancer Research and Treatment, 1996; 38: 169-176. |
| Cornish et al.; Quantification of lymphoedema using multi-frequency bioimpedance; Applied Radiation and Isotopes, Elsevier, Oxford, GB, 1998; 49(5/6): 651-652. |
| De Luca et al.; Use of low-frequency electrical impedance mesurements to determine phospholipid content in amniotic fluid; Physics in Medicine and Biology, 1996; 41: 1863-1869. |
| Derwent; Abstract No. 97-474414, JP 09 220209 A (Sekisui Chem, Ind. Co. Ltd.), Aug. 26, 1997; Abstract. |
| Derwent; Abstract No. 98-138541, JP 10 014898 A (Sekisui Chem, Ind. Co. Ltd.), Jan. 20, 1998; Abstract. |
| Derwent; Abstract No. 99-247542, JP 11 070090 A (Sekisui Chem. Ind. Co. Ltd.), Mar. 16, 1999; Abstract. |
| Deurenberg et al.; Multi-frequency bioelectrical impedance: a comparison between the Cole-Cole modelling and Hanai equations with the classical impedance index approach; Annals of Human Biology, 1996; 23(1): 31-41. |
| Kim et al.; Bioelectrical impedance changes in regional extracellular fluid alterations; Electromyography and Clinical Neurophysiology, 1997; 37: 297-304. |
| Rigaud et al.; Biolectrical impedance techniques in medicine; Critical Reviews in Biomedical Engineering, 1996; 24 (4-6): 257-351. |
| Steijaert et al.; The use of multi-frequency impedance to determine total body water and extracellular water in obese and lean female individuals; International Journal of Obesity, 1997; 21: 930-934. |
| Ward et al.; Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post-mastectomy patients; European J. of Clin. Investigation, 1992; 22: 751-754. |
| European Search Report for EP 07718972.8-1265 / 2020918 (Impedimed, Ltd.), mailed on Mar. 2, 2010, 4 pages. |
| Derwent; Abstract No. 98-138542, JP 10 014899 A (Sekisui Chem, Ind. Co. Ltd.), Feb. 20, 1998; Abstract. |
| Ellis et al.; Human hydrometry: comparison of multifrequency biolectrical impedance with 2H2O and bromine dilution; Journal of Applied Physiology; 1998; 85(3): 1056-1062. |
| Jones et al.; Extracellular fluid volume determined by bioelectric impedance and serum albumin in CAPD patients; Nephrology Dialysis Transplantation; 1998; 13: 393-397. |
| Thomas B.J.; Future technologies; Asia Pacific Journal Clinical Nutrition; 1995; 4: 157-159. |
| Schneider, I.; Broadband signals for electrical impedance measurements for long bone fractures; Engineering in Medicine and Biology Society, 1996. Bridging Disciplines for Biomedicine. Proceedings of the 18th Annual International Conference of the IEEE; Oct. 31, 1996; 5: 1934-1935. |
| Woodrow et al.; Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis; Nephrology Dialysis Transplantation; 2000; 15: 862-866. |
| Boulier et al.; Fat-Free Mass Estimation by Two Electrode Impedance Method; American Journal of Clinical Nutrition; 1990; 52: 581-585. |
| McDougal et al.; Body Composition Measurements from Whole Body Resistance and Reactance; Surgical Forum; 1986; 36: 43-44. |
| Tedner, B.; Equipment using Impedance Technique for Automatic Recording of Fluid-Volume Changes during Hemodialysis; Medical & Biological Engineering & Computing; 1983; 285-290. |
| Lukaski et al.; Estimation of Body Fluid Volumes using Tetrapolar Bioelectrical Impedance Measurements; Aviation, Space, and Environmental Medicine; Dec. 1988; 1163-1169. |
| Lozano et al.; Two-frequency impedance plethysmograph: real and imaginary parts; Medical & Biological Engineering & Computing; Jan. 1990; 28(1): 38-42. |
| Chaudary et al.; Dielectric Properties of Normal & Malignant Human Breast Tissues at Radiowave and Microwave Frequencies; Indian Journal of Biochemistry & Biophysics; 1984; 21(1): 76-79. |
| Jossinet et al.; A study for breast imaging with a circular array of impedance electrodes; Proc. Vth Int. Conf. Bioelectrical Impedance, 1981, Tokyo, Japan; 1981; 83-86. |
| Jossinet et al.; Technical Implementation and Evaluation of a Bioelectrical Breast Scanner; Proc. 10.supth Int. Conf. IEEE Engng. Med. Biol., 1988, New Orleans, USA (Imped. Imaging II); 1988; 1: 289. |
| Man et al.; Results of Preclinical Tests for Breast Cancer Detection by Dielectric Measurements; XII Int. Conf. Med. Biol. Engng. 1979, Jerusalem, Israel. Springer Int., Berlin; 1980; Section 30.4. |
| Pethig et al.; The Passive Electrical Properties of Biological Systems: Their Significance in Physiology, Biophysics and Biotechnology; Physics in Medicine and Biology; 1987; 32: 933-970. |
| Piperno et al.; Breast Cancer Screening by Impedance Measurements; Frontiers of Medical & Biological Engineering; 1990; 2: 111-117. |
| Skidmore et al.; A Data Collection System for Gathering Electrical Impedance Measurements from the Human Breast; Clinical Physics Physiological Measurement; 1987; 8: 99-102. |
| Sollish et al.; Microprocessor-assisted Screening Techniques; Israel Journal of Medical Sciences; 1981; 17: 859-864. |
| Surowiec et al.; Dielectric Properties of Breast Carcinima and the Surrounding Tissues; IEEE Transactions on Biomedical Engineering; 1988; 35: 257-263. |
| Al-Hatib, F.; Patient Instrument Connection Errors in Bioelectrical Impedance Measurement; Physiological Measurement; May 2, 1998; 19(2): 285-296. |
| Gersing, E.; Impedance Spectroscopy on Living Tissue for Determination of the State of Organs; Bioelectrochemistry and Bioenergetics; 1998; 45: 145-149. |
| Mattar, J.A.; Application of Total Body Impedance to the Critically III Patient; New Horizons; 1996; 4(4): 493-503. |
| Ott et al.; Bioelectrical Impedance Analysis as a Predictor of Survival in Patients with Human Immunodeficiency Virus Infection; Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology; 1995; 9: 20-25. |
| U.S. Appl. No. 12/516,876, filed Jul. 1, 2010, Chetham. |
| U.S. Appl. No. 12/596,833, filed Jun. 17, 2010, Ward. |
| U.S. Appl. No. 12/600,244, Chetham. |
| U.S. Appl. No. 12/672,893, filed Feb. 24, 2011, Cornish. |
| U.S. Appl. No. 10/767,825, filed Sep. 23, 2004, Ward. |
| U.S. Appl. No. 12/302,914, filed Apr. 8, 2010, McGree. |
| U.S. Appl. No. 13/128,631, Essex. |
| Thomas et al.; Bioelectrical impedance analysis for measurement of body fluid volumes—A review; Journal of Clinical Engineering; 1992; 17(16): 505-510. |
| Ward et al.; There is a better way to measure Lymphedema; National Lymphedema Network Newsletter; Oct. 1995; 7 (4): 89-92. |
| Cornish et al.; Alteration of the extracellular and total body water volumes measured by multiple frequency bioelectrical impedance analysis; Nutrition Research; 1994; 14(5): 717-727. |
| Cornish et al.; Early diagnosis of lymphedema using multiple frequency bioimpedance; Lymphology; Mar. 2001; 34: 2-11. |
| Cornish et al.; Early diagnosis of lymphoedema in postsurgery breast cancer patients; Annals New York Academy of Sciences; May 2000; 571-575. |
| Brown et al.; Relation between tissue structure and imposed electrical current flow in cervical neoplasia; The Lancet; Mar. 11, 2000; 355 (9207): 892-895. |
| Iacobellis, G. et al.; Influence of excess fat on cardiac morphology and function: Study in Uncomplicated obesity; Obesity Research; Aug. 8, 2002; 10 (8): 767-773. |
| Bella, J. N. et al.; Relations of left ventricular mass to fat-free and adipose body mass: The Strong Heart Study; Circulation; Dec. 12, 1998; 98: 2538-2544. |
| Yoshinaga, M. et al.; Effect of total adipose weight and systemic hypertension on left ventricular mass in children; American Journal of Cardiology; Oct. 15, 1995; 76: 785-787. |
| Karason, K. et al.; Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure; European Heart Journal; Jan. 1, 2003; 24: 1500-1505. |
| Abdullah M. Z.; Simulation of an inverse problem in electrical impedance tomography using resistance electrical network analogues; International Journal of Electrical Engineering Education; Oct. 1999; 36 (4): 311-324. |
| Dines et al.; Analysis of electrical conductivity imaging; Geophysics; Jul. 1981; 46 (7): 1025-1036. |
| Osterman et al.; Multifrequency electrical impedance imaging: preliminary in vivo experience in breast; Physiological Measurement; Feb. 2000; 21 (1): 99-109. |
| Ward et al.; Determination of Cole parameters in multiple frequency bioelectrical impedance analysis using only the measurement of impedances; Four-frequenct fitting; Physiological Measurement; Sep. 2006; 27 (9): 839-850. |
| Bernstein; A new stroke volume equation for thoracic electrical bio impedance; Critical Care Medicine; 1986; vol. 14; pp. 904-909. |
| McAdams et al.; Tissue Impedance: a historical overview; Physiological Measurement, Institute of Physics Publishing, Bristol, GB; 16 (3A); pp. 1l-A13; Aug. 1, 1995. |
| D'Entremont et al. “Impedance spectroscopy: an accurate method of differentiating between viable and ischaemic or infarcted muscle tissue” Med. Biol. Eng. Comput., 2002, 40: 380-87. |
| Zhu et al., “Dynamics of segmental extracellular volumes during changes in body position by bioimpedance analysis”; J. App. Physiol.; 1998, vol. 85, pp. 497-504. |
| McCullagh, W. A., et al., Bioelectrical impedance analysis measures the ejection fraction of the calf muscle pump, IFMBE Proceedings, 2007; vol. 17, p. 619. |
| Scharfetter, Effect of postural changes on the reliability of volume estimations from bioimpedance spectroscopy data, Kidney International Apr. 1997, vol. 51, No. 4, pp. 1078-1087. |
| Ezenwa, Multiple frequency system for body composition measurement, Medical Informatics, Ethics, Cardiology, Instrumentation., Proceedings of the Annual International Conference of the Engineering in Medicine and Biology Society, Oct. 28, 1993, vol. 15, Part 02. |
| Yamakoshi, Non-Invasive Cardiovascular Hemodynamic Measurements, Sensors in Medicine and Health Care, 2004, pp. 107-160. |
| Ivorra, Bioimpedance dispersion width as a parameter to monitor living tissues, Physiological Measurement, 2005, vol. 26, S165-S173. |
| Number | Date | Country | |
|---|---|---|---|
| 20110313311 A1 | Dec 2011 | US |
